Subsequently, SIRT1 regulates the migration of tumor-associated macrophages (TAMs) through the CXCR4/CXCL12 pathway, which inhibits the proliferation and activity of CD8+ T cells (Fang et al., 2022). Here, CXCL12 is linked to neoplasm.